Max Healthcare Institute Ltd
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
- Market Cap ₹ 1,06,257 Cr.
- Current Price ₹ 1,092
- High / Low ₹ 1,314 / 934
- Stock P/E 151
- Book Value ₹ 87.3
- Dividend Yield 0.14 %
- ROCE 12.5 %
- ROE 9.45 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 203% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 18.7%
Cons
- Stock is trading at 12.5 times its book value
- Company has a low return on equity of 9.70% over last 3 years.
- Earnings include an other income of Rs.293 Cr.
- Debtor days have increased from 33.1 to 40.5 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 591 | 790 | 912 | 984 | 1,059 | 1,008 | 59 | 1,031 | 1,775 | 1,905 | 2,341 | 2,664 | 2,800 | |
| 615 | 768 | 890 | 941 | 1,048 | 976 | 65 | 870 | 1,332 | 1,321 | 1,579 | 1,830 | 2,020 | |
| Operating Profit | -24 | 22 | 22 | 43 | 11 | 31 | -6 | 161 | 443 | 584 | 762 | 833 | 780 |
| OPM % | -4% | 3% | 2% | 4% | 1% | 3% | -10% | 16% | 25% | 31% | 33% | 31% | 28% |
| 39 | 33 | 35 | 30 | 51 | 47 | 66 | -104 | 128 | 144 | 271 | 293 | 293 | |
| Interest | 42 | 43 | 30 | 35 | 41 | 44 | 60 | 112 | 59 | 52 | 52 | 48 | 38 |
| Depreciation | 31 | 49 | 50 | 51 | 49 | 53 | 3 | 91 | 112 | 113 | 117 | 131 | 144 |
| Profit before tax | -58 | -38 | -24 | -13 | -28 | -18 | -3 | -146 | 400 | 563 | 865 | 947 | 891 |
| Tax % | 0% | 0% | -0% | 0% | 0% | 26% | -5% | 12% | 17% | -23% | 21% | 26% | |
| -58 | -38 | -24 | -13 | -28 | -23 | -3 | -164 | 332 | 694 | 687 | 701 | 691 | |
| EPS in Rs | -1.46 | -0.78 | -0.44 | -0.24 | -0.51 | -0.43 | -0.06 | -1.70 | 3.42 | 7.15 | 7.07 | 7.21 | 7.10 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 14% | 21% | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 114% |
| 3 Years: | 14% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 203% |
| 3 Years: | 32% |
| TTM: | -14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 43% |
| 3 Years: | 36% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 8% |
| 3 Years: | 10% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 395 | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 | 972 |
| Reserves | 167 | 523 | 762 | 770 | 773 | 749 | 2,338 | 4,973 | 5,342 | 6,071 | 6,709 | 7,317 | 7,523 |
| 505 | 296 | 273 | 314 | 386 | 390 | 658 | 480 | 556 | 534 | 443 | 612 | 705 | |
| 223 | 141 | 171 | 210 | 278 | 274 | 20 | 724 | 945 | 845 | 945 | 1,065 | 1,176 | |
| Total Liabilities | 1,290 | 1,449 | 1,740 | 1,832 | 1,973 | 1,951 | 3,553 | 7,143 | 7,812 | 8,420 | 9,069 | 9,967 | 10,376 |
| 468 | 430 | 424 | 429 | 502 | 479 | 90 | 2,989 | 4,493 | 4,485 | 4,717 | 4,871 | 4,890 | |
| CWIP | 10 | 15 | 6 | 30 | 7 | 10 | 0 | 8 | 60 | 103 | 235 | 277 | 345 |
| Investments | 238 | 451 | 840 | 866 | 799 | 770 | 2,471 | 2,379 | 1,447 | 1,475 | 1,915 | 2,614 | 2,613 |
| 574 | 554 | 469 | 508 | 665 | 693 | 992 | 1,766 | 1,811 | 2,358 | 2,202 | 2,206 | 2,527 | |
| Total Assets | 1,290 | 1,449 | 1,740 | 1,832 | 1,973 | 1,951 | 3,553 | 7,143 | 7,812 | 8,420 | 9,069 | 9,967 | 10,376 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 64 | 33 | 52 | -19 | -36 | 219 | 447 | 696 | 613 | 598 | ||
| -200 | -330 | -66 | -89 | 55 | -2,536 | -84 | -670 | -843 | -806 | -873 | ||
| 176 | 251 | 34 | 36 | -36 | 2,332 | 397 | -161 | -54 | -246 | -29 | ||
| Net Cash Flow | 15 | -16 | 0 | -0 | -0 | -240 | 532 | -384 | -201 | -438 | -304 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97 | 67 | 48 | 55 | 68 | 103 | 517 | 109 | 56 | 27 | 32 | 40 |
| Inventory Days | 18 | 20 | 18 | 19 | 22 | 25 | 33 | 20 | 31 | 24 | 20 | |
| Days Payable | 158 | 171 | 183 | 206 | 250 | 335 | 297 | 159 | 226 | 225 | 191 | |
| Cash Conversion Cycle | -42 | -85 | -117 | -132 | -161 | -206 | 517 | -155 | -83 | -169 | -169 | -130 |
| Working Capital Days | -54 | -15 | -33 | -20 | -27 | 14 | -493 | 27 | 5 | -45 | -32 | -24 |
| ROCE % | 0% | 1% | 1% | 2% | 2% | 4% | 7% | 9% | 12% | 13% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
21 Feb - Appeal partly allowed: revised GST ₹85.36 lakh, penalty ₹85.36 lakh, interest ₹6.89 lakh; received 20 Feb 2026.
- Announcement under Regulation 30 (LODR)-Investor Presentation 20 Feb
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
12 Feb - Transcript of Earnings Call held on February 6, 2026
- Announcement under Regulation 30 (LODR)-Investor Presentation 7 Feb
-
Audio Recording Of Earnings Call Held On February 6, 2026
6 Feb - Audio recording of Feb 6, 2026 earnings call for Q3 and nine months ended Dec 31, 2025 available on website.
Annual reports
Concalls
-
Feb 2026Transcript PPT
-
Feb 2026TranscriptAI SummaryPPT REC
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Nov 2025TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT REC
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025Transcript PPT REC
-
Jan 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT REC
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptAI SummaryPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Feb 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Feb 2021TranscriptAI SummaryPPT
-
Nov 2020TranscriptAI SummaryPPT
-
Sep 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
Leadership[1]
The company is India’s largest hospital chain in terms of market cap and 2nd largest hospital in terms of revenue and EBITDA.